KIMBERLY QUEEN: Open Payments
NPI 1538677679 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 48 payments from 14 companies in 2025. Trend: 2023 $247 · 2024 $501 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $293 |
| Phathom Pharmaceuticals, Inc. | 7 | $190 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $172 |
| ABBVIE INC. | 11 | $167 |
| Otsuka America Pharmaceutical, Inc. | 1 | $137 |
| Actelion Pharmaceuticals US, Inc. | 1 | $109 |
| QOL Medical, LLC | 2 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| Janssen Biotech, Inc. | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
Products named: VOQUEZNA, XIFAXAN, FASENRA, REXULTI, BREZTRI, DUPIXENT, UPTRAVI, Sucraid.
Industry payments across GA — which companies pay providers there.
